Recommended Treatments for Managing Hypertension
The most effective approach to managing hypertension combines lifestyle modifications with pharmacological therapy, typically starting with a combination of a renin-angiotensin system (RAS) blocker (ACE inhibitor or ARB) with either a dihydropyridine calcium channel blocker (CCB) or thiazide/thiazide-like diuretic for most patients with confirmed hypertension (BP ≥140/90 mmHg). 1, 2
Diagnosis and Classification
- Hypertension is defined as persistent systolic blood pressure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) ≥90 mmHg 1
- Blood pressure should be measured using a validated device with the patient seated, arm at heart level, with at least two measurements at each visit 2
- Classification of blood pressure:
- Normal: <120/80 mmHg
- Elevated/Prehypertension: 130-139/80-89 mmHg
- Stage 1: 140-159/90-99 mmHg
- Stage 2: ≥160/100 mmHg 2
- Ambulatory or home blood pressure monitoring should be considered for suspected white coat hypertension 1, 2
Lifestyle Modifications
Lifestyle modifications are recommended for all patients with elevated blood pressure and should complement pharmacological therapy: 1, 2, 3
- Weight reduction to achieve ideal body weight 4, 5
- Regular physical activity (predominantly dynamic exercise like brisk walking) 4, 6
- Dietary modifications:
- Alcohol moderation (≤14 units/week for men, ≤9 units/week for women) or preferably avoidance 1, 5
- Smoking cessation 1
- Stress management techniques when appropriate 5
Pharmacological Treatment
When to Initiate Drug Therapy
- Immediate initiation of drug therapy is recommended for:
- Urgent treatment is needed for BP ≥180/110 mmHg 2
First-Line Drug Therapy
First-line drugs include: 1, 2, 3
- ACE inhibitors
- Angiotensin receptor blockers (ARBs)
- Calcium channel blockers (CCBs), particularly dihydropyridines
- Thiazide or thiazide-like diuretics
For most patients with confirmed hypertension (BP ≥140/90 mmHg), combination therapy is recommended as initial treatment 1, 2
Preferred combinations include a RAS blocker (ACE inhibitor or ARB) with either a dihydropyridine CCB or thiazide/thiazide-like diuretic 1, 2
Fixed-dose single-pill combinations are recommended to improve adherence 1
Beta-blockers are recommended when there are specific indications such as angina, post-myocardial infarction, heart failure with reduced ejection fraction, or for heart rate control 1
Treatment Algorithm
- Initial therapy: Start with combination of RAS blocker + CCB or thiazide/thiazide-like diuretic 1, 2
- If BP not controlled: Increase to triple therapy with RAS blocker + CCB + thiazide/thiazide-like diuretic 1
- If BP still not controlled: Consider adding a fourth agent or referral to a specialist 1
Important Cautions
- Combining two RAS blockers (ACE inhibitor and ARB) is not recommended 1
- Monitor for orthostatic hypotension, especially in elderly patients 1
- Medications should be taken at the most convenient time of day to establish a habitual pattern and improve adherence 1
Blood Pressure Targets
- For most adults: Target systolic BP 120-129 mmHg 1, 2
- For patients with diabetes, chronic kidney disease, or established cardiovascular disease: Target BP <130/80 mmHg 1, 2
- For elderly patients (≥80 years): Maintain treatment if well tolerated 1, 2
Special Populations and Comorbidities
- Coronary Artery Disease: RAS blockers and beta-blockers are first-line, with or without CCBs 1
- Previous Stroke: RAS blockers, CCBs, and diuretics are first-line 1
- Heart Failure: RAS blockers, beta-blockers, and mineralocorticoid receptor antagonists are recommended 1
- Chronic Kidney Disease: RAS blockers are preferred, especially in the presence of proteinuria 8
- Left Ventricular Hypertrophy: ARBs like losartan are indicated to reduce stroke risk (note: this benefit may not apply to Black patients) 8
Additional Cardiovascular Risk Reduction
- Aspirin: Consider low-dose aspirin (75 mg daily) for secondary prevention or primary prevention in patients aged ≥50 years with controlled BP and high cardiovascular risk 1
- Statins: Recommended for patients with established cardiovascular disease or those at high risk (≥20% 10-year risk) 1
Monitoring and Follow-up
- Allow at least four weeks to observe the full response to medication changes 1
- Regular BP monitoring is necessary, with home readings when possible 2
- Annual reassessment of cardiovascular risk is recommended 2
- Evaluate medication adherence at each visit 1
By following this comprehensive approach to hypertension management, focusing on both lifestyle modifications and appropriate pharmacological therapy, the risk of cardiovascular morbidity and mortality can be significantly reduced.